ACIST Medical Systems, Inc., a world-leading provider of contrast-delivery systems for cardiology and radiology imaging, announced today that HealthTrust Purchasing Group, LP (HealthTrust), Brentwood, Tenn., one of the leading health care group purchasing organizations, has awarded the company a three-year contract, effective December 1, 2009, for ACIST cardiovascular injection technology, the ACIST | CVi® Contrast Delivery System.
“Our agreement with HealthTrust to provide the ACIST CVi contrast injection system demonstrates our goals of streamlining the process of placing quality, clinically beneficial, and cost-effective technology in the hands of clinicians more quickly and efficiently”
The ACIST CVi system is an advanced contrast injector that, in one device, provides a method of contrast injection for all cardiac and vascular angiography procedures. The ACIST CVi technology was developed with the primary purpose of enabling the cardiologist to achieve greater focus on the image and the patient, instead of on stopcocks, syringes, tubing, and other equipment. ACIST’s advanced, variable flow-rate injection systems have demonstrated procedural efficiency, cost savings, and reduction in contrast dosing to the patient, when compared to traditional hand-manifold and power injection methods.
“Our agreement with HealthTrust to provide the ACIST CVi contrast injection system demonstrates our goals of streamlining the process of placing quality, clinically beneficial, and cost-effective technology in the hands of clinicians more quickly and efficiently,” explained Fulvio Renoldi-Bracco, Head of the Bracco Imaging Global Business Unit and CEO of ACIST Medical Systems, Inc. “This agreement provides HealthTrust members the opportunity to access the CVi injection system and provide a real benefit to their hospitals, their physicians and staff, and, most importantly, to the patients they treat.”
Source: ACIST Medical Systems